Main / Activity / SFUS, Belgrad 2015

5th International Conference
Challenges for Efficient Health Care
in Central Eastern Europe
Belgrade, Serbia, 9th and 10th of October 2015 | Registration on-line
About conference
Central and Eastern European healthcare providers face a wide range of unique and difficult challenges which must be addressed in order to meet the ever growing demands and expectations of their services. From healthcare financing, a perception of insufficient evidence to base decision making, through to difficult questions such as special diseases and the role of pharmaceuticals, this conference aims to address these specific challenges and provide solutions which will enable participants to improve the health of the populations they serve.
Applying Budget Impact and Cost Effectiveness Analysis (BIA and CEA) is an ever more important practice in Healthcare decision making. National regulatory agencies across the world, have required for several years that companies submit estimates of both the cost-effectiveness and the likely impact of the new health-care interventions on national, regional, or local health plan budgets.
This important trend has been followed closely by Central and Eastern European Countries, with Serbia for example making both CEA and BIA a compulsory part of their submission process in April of 2014.
Despite the efforts to standardise both BIA and CEA in highly developed nations, local health care, epidemiology, information availability and available local skills reflect a very different environment for submissions within Central and Eastern European Countries.
This presents the unique challenge of greater evidence synthesis requirements for similar quality submissions, while at the same time a lack of local skills and ability to pay for the education to acquire them makes even the simplest submission a difficult task.
Attendees to the Workshop day, on the 10th of October 2015, Hotel Metropol, Belgrade, Serbia will have the opportunity to meet highly experienced practitioners of both BIA and CEA, who have worked extensively on constructing such submissions both for the developed markets and regionally. Providing unique insight into the means used to address these problems and learn the important skills required to construct a good submission for the region, as well as the common mistakes which plague such submissions currently.
This will culminate at the end of the day, when participants engage in a competitive war game, putting their acquired knowledge and skill to the test in a simulated patient population in Serbia. This simulation combines the recent advent of Central Tendering in Serbia, with skills and models for the Rheumatoid Arthritis and for the Hepatitis C Virus (HCV) to travel into a plausible future where HCV is cured in Serbia.
  • Prof. dr Brian Godman PhD, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK; Karolinska Institute, Sweden
  • Alan Haycox MSc, Health Economics Unit, University of Liverpool Management School, UK
  • Livio Garattini, Mario Negri Institute, Milan, Italy
  • Norbert Wilk, Arcana Institute, Poland
  • Jakub Adamski, Arcana Institute, Poland
  • Stephan Korte, Novartis
  • Neven Lovrinov MSc Pharm, Terminal d.o.o., Croatia
  • Wija Oortwijn PhD, Partner at ECORYS NL, The Netherlands
  • Krzysztof Landa MD, President at MedInvest Scanner Ltd M.I.S., Poland
  • Mark Parker MSc, Health Economics Unit, University of Liverpool Management School, UK
  • Angela Yu MSc, London School of Economics, UK
  • Timothy Johnston, Program Leader for Inclusive Growth and Human Development, Southeast Europe, Europe and Central Asia Region, World Bank
  • Dávid Dankó PhD, Managing Director at Ideas & Solutions, Hungary
  • Dr. Günter Harms, Market Access and Public Affairs Director, Shire, Germany
  • Vanesa Benkovic MSc, Senior HTA and health research consultant, Croatia
  • Bojan Trkulja MD, Managing Director at INOVIA, Serbia
  • Tanja Novakovic MSc Pharm, President of Pharmacoeconomics Section, Serbia, Representative of Chamber of Commerce and Industry of Serbia
  • Jovan Mihajlovic, MSc Pharm, Unit of Pharmacoepidemiology & Pharmacoeconomics, Department of Pharmacy, University of Groningen, The Netherlands
We recommend
EBHC Symposium
© Ceestahc.org   Wykonała: Agencja A.R.T.   Wyświetleń:5427, Data modyfikacji:2015-10-05